Metalloproteases as potential therapeutic targets in arthritis treatment.
about
ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammationDegradome expression profiling in human articular cartilage.The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases.Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?Small molecules for bone diseases.The role of ADAMTSs in arthritisEpigenetic mechanisms and non-coding RNAs in osteoarthritis.Matrix metalloproteinase 13 expression in response to double-stranded RNA in human chondrocytes.Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitorsMatriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple MechanismsTargeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase InhibitorThe serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover.Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation.In silico study combining docking and QSAR methods on a series of matrix metalloproteinase 13 inhibitors.Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.
P2860
Q33607501-9C2F409A-C953-4A23-935C-5BFA6F8BC3CAQ37270886-1D1D9FC9-838A-449C-AD8E-4D7FBED48006Q37358106-8C7EA2BA-7650-4CCD-919F-E7D436B47E6AQ37358225-A572C01E-700D-43DA-A458-9BF05C8D9805Q37714909-433E8F61-B02F-4B8B-B6B2-E4D31BB798E9Q37825835-C4393833-3F97-47AB-B4A0-C32D8D980240Q38124278-A0D832C1-C37F-4C73-A3D6-8B732BD2F4CFQ39207621-E1BC3DBE-2C7B-4AB5-82CF-1CB96EA14A43Q39669677-0B42C6DD-D169-4324-B9D6-6A43E2859086Q41785296-227BE734-9572-4745-8E50-DABBF5D44AFAQ41963141-10FD1E66-4849-4970-8092-CB482D2A3190Q42291702-716C8A50-CDFD-41E7-99CD-B52830CADF6AQ47168535-B6E672F4-D785-46E8-BA69-48F420DFBACBQ51015488-19AB67E3-D09D-42CB-837F-8AC0BA70E40AQ51017366-A1027A18-6FDE-4670-83C7-A62C850BF04CQ55023431-B20C50FD-3119-4D6F-8FD0-28B92596E362
P2860
Metalloproteases as potential therapeutic targets in arthritis treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metalloproteases as potential therapeutic targets in arthritis treatment.
@en
Metalloproteases as potential therapeutic targets in arthritis treatment.
@nl
type
label
Metalloproteases as potential therapeutic targets in arthritis treatment.
@en
Metalloproteases as potential therapeutic targets in arthritis treatment.
@nl
prefLabel
Metalloproteases as potential therapeutic targets in arthritis treatment.
@en
Metalloproteases as potential therapeutic targets in arthritis treatment.
@nl
P2093
P2860
P356
P1476
Metalloproteases as potential therapeutic targets in arthritis treatment.
@en
P2093
Andrew D Rowan
Gary J Litherland
Jennifer M Milner
P2860
P356
10.1517/14728222.12.1.1
P407
P577
2008-01-01T00:00:00Z